scholarly journals APC Splicing Mutations Leading to In-Frame Exon 12 or Exon 13 Skipping Are Rare Events in FAP Pathogenesis and Define the Clinical Outcome

Genes ◽  
2021 ◽  
Vol 12 (3) ◽  
pp. 353
Author(s):  
Vittoria Disciglio ◽  
Giovanna Forte ◽  
Candida Fasano ◽  
Paola Sanese ◽  
Martina Lepore Signorile ◽  
...  

Familial adenomatous polyposis (FAP) is caused by germline mutations in the tumor suppressor gene APC. To date, nearly 2000 APC mutations have been described in FAP, most of which are predicted to result in truncated protein products. Mutations leading to aberrant APC splicing have rarely been reported. Here, we characterized a novel germline heterozygous splice donor site mutation in APC exon 12 (NM_000038.5: c.1621_1626+7del) leading to exon 12 skipping in an Italian family with the attenuated FAP (AFAP) phenotype. Moreover, we performed a literature meta-analysis of APC splicing mutations. We found that 119 unique APC splicing mutations, including the one described here, have been reported in FAP patients, 69 of which have been characterized at the mRNA level. Among these, only a small proportion (9/69) results in an in-frame protein, with four mutations causing skipping of exon 12 or 13 with loss of armadillo repeat 2 (ARM2) and 3 (ARM3), and five mutations leading to skipping of exon 5, 7, 8, or (partially) 9 with loss of regions not encompassing known functional domains. The APC splicing mutations causing skipping of exon 12 or 13 considered in this study cluster with the AFAP phenotype and reveal a potential molecular mechanism of pathogenesis in FAP disease.

Author(s):  
Vittoria Disciglio ◽  
Giovanna Forte ◽  
Candida Fasano ◽  
Paola Sanese ◽  
Martina Lepore Signorile ◽  
...  

Familial adenomatous polyposis (FAP) is caused by germline mutations in the tumor suppressor gene APC. To date, nearly 2000 APC mutations have been described in FAP, most of which are predicted to result in truncated protein products. Mutations leading to aberrant APC splicing have rarely been reported. Here, we characterized a novel germline heterozygous splice donor site mutation in APC exon 12 (NM_000038.5: c.1621_1626+7del) leading to exon 12 skipping in an Italian family with the attenuated FAP (AFAP) phenotype. Moreover, we performed a literature me-ta-analysis of APC splicing mutations. We found that 123 unique APC splice site mutations, in-cluding the one described here, have been reported in FAP patients, 69 of which have been char-acterized at the mRNA level. Among these, only a small proportion (9/69) results in an in-frame protein, with 4 mutations causing skipping of exon 12 and/or 13 with loss of armadillo repeat 2 (ARM2) and 3 (ARM3), and 5 mutations leading to skipping of exon 5, 7, 8, and (partially) 9 with loss of regions not encompassing known functional domains. The APC splicing mutations considered in this study cluster with the AFAP phenotype and delineate a novel molecular mechanism of pathogenesis in FAP disease.


Gene ◽  
2013 ◽  
Vol 532 (2) ◽  
pp. 297-301 ◽  
Author(s):  
Xiuyan Shi ◽  
Chunyan Ji ◽  
Lihua Cao ◽  
Yuhong Wu ◽  
Yuyang Shang ◽  
...  

2012 ◽  
Vol 11 (4) ◽  
pp. 559-564 ◽  
Author(s):  
Masanobu Takahashi ◽  
Yoichi Furukawa ◽  
Hideki Shimodaira ◽  
Masato Sakayori ◽  
Takuya Moriya ◽  
...  

2000 ◽  
Vol 110 (3) ◽  
pp. 694-698 ◽  
Author(s):  
C. L. Harteveld ◽  
C. Beijer ◽  
P. Van Delft ◽  
R. Zanardini ◽  
L. F. Bernini ◽  
...  

1999 ◽  
Vol 277 (2) ◽  
pp. C225-C232 ◽  
Author(s):  
Hiroyuki Nakaura ◽  
Sachio Morimoto ◽  
Fumi Yanaga ◽  
Masashi Nakata ◽  
Hirofumi Nishi ◽  
...  

A splice donor site mutation in intron 15 of the cardiac troponin T (TnT) gene has been shown to cause familial hypertrophic cardiomyopathy (HCM). In this study, two truncated human cardiac TnTs expected to be produced by this mutation were expressed in Escherichia coli and partially (50–55%) exchanged into rabbit permeabilized cardiac muscle fibers. The fibers into which a short truncated TnT, which lacked the COOH-terminal 21 amino acids because of the replacement of 28 amino acids with 7 novel residues, had been exchanged generated a Ca2+-activated maximum force that was slightly, but statistically significantly, lower than that generated by fibers into which wild-type TnT had been exchanged when troponin I (TnI) was phosphorylated by cAMP-dependent protein kinase. A long truncated TnT simply lacking the COOH-terminal 14 amino acids had no significant effect on the maximum force-generating capability in the fibers with either phosphorylated or dephosphorylated TnI. Both these two truncated TnTs conferred a lower cooperativity and a higher Ca2+ sensitivity on the Ca2+-activated force generation than did wild-type TnT, independent of the phosphorylation of TnI by cAMP-dependent protein kinase. The results demonstrate that the splice donor site mutation in the cardiac TnT gene impairs the regulatory function of the TnT molecule, leading to an increase in the Ca2+ sensitivity, and a decrease in the cooperativity, of cardiac muscle contraction, which might be involved in the pathogenesis of HCM.


Hemoglobin ◽  
2006 ◽  
Vol 30 (1) ◽  
pp. 3-7 ◽  
Author(s):  
Cornelis L. Harteveld ◽  
Max C. W. Jebbink ◽  
Nico van der Lely ◽  
Peter van Delft ◽  
Nicole Akkermans ◽  
...  

2016 ◽  
Vol 64 (5) ◽  
pp. 364 ◽  
Author(s):  
Xiuqing Zhang ◽  
Juan Bu ◽  
Sijie He ◽  
Lejin Wang ◽  
Jiankang Li ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document